CanadaBis Capital (TSXV:CANB) E10: C$-0.03 (As of Oct. 2025)


What is CanadaBis Capital E10?

CanadaBis Capital TSXV:CANB E10 is C$-0.03 as of Oct. 2025. The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

CanadaBis Capital's adjusted earnings per share data for the fiscal year that ended in Jul. 2025 was C$-0.010. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is C$-0.03 for the trailing ten years ended in Jul. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-28), CanadaBis Capital's current stock price is C$ 0.015. CanadaBis Capital's E10 for the fiscal year that ended in Jul. 2025 was C$-0.03. CanadaBis Capital's Shiller PE Ratio of today is .


CanadaBis Capital  (TSXV:CANB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


CanadaBis Capital E10 Related Terms


CanadaBis Capital E10 Historical Data

* Premium members only.

The historical data trend for CanadaBis Capital's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CanadaBis Capital E10 Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.03

CanadaBis Capital Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.03 0.00

TSXV:CANB vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanadaBis Capital Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's Shiller PE Ratio falls into.



CanadaBis Capital E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CanadaBis Capital's adjusted earnings per share data for the fiscal year that ended in Jul. 2025 was:

Adj_EPS=Earnings per Share (Diluted) /CPI of Jul. 2025 (Change)*Current CPI (Jul. 2025)
=-0.01/130.2871*130.2871
=-0.010

Current CPI (Jul. 2025) = 130.2871.

CanadaBis Capital Annual Data

per_share_eps CPI Adj_EPS
201611 0.000 101.607 0.000
201712 -0.020 103.345 -0.025
201812 -0.020 105.399 -0.025
201907 -0.090 108.243 -0.108
202007 -0.040 108.401 -0.048
202107 -0.020 112.431 -0.023
202207 0.004 120.964 0.004
202307 0.030 124.914 0.031
202407 0.000 128.075 0.000
202507 -0.010 130.287 -0.010

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of C$-0.03 mean?
CanadaBis Capital (TSXV:CANB) has a E10 of C$-0.03 as of Oct. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on CanadaBis Capital and its competitors.
Is CanadaBis Capital's E10 too high?
CanadaBis Capital's current E10 is C$-0.03.
How does CanadaBis Capital's E10 compare to ZTS?
CanadaBis Capital's E10 of C$-0.03 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on CanadaBis Capital and its competitors. CanadaBis Capital's current E10 is C$-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanadaBis Capital stock overvalued right now?
CanadaBis Capital (TSXV:CANB) has a current E10 of C$-0.03. The stock's GF Value™ is C$0.07, compared to a current price of C$0.02 — trading 78.6% below its estimated fair value. The current E10 is C$-0.03. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For CanadaBis Capital (TSXV:CANB), the current E10 is C$-0.03 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CanadaBis Capital Business Description

Other Exchanges CNADF:USA
Address 255C Clearview Drive, Red Deer County, Red Deer, AB, CAN, T4E 3B6
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.